FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009604927> ?p ?o ?g. }

• W2009604927 endingPage "185" @default.
• W2009604927 startingPage "179" @default.
• W2009604927 abstract "Recent clinical studies have shown that inorganic arsenic trioxide (As(2)O(3)) at low concentrations induces complete remission with minimal toxicity in patients with refractory acute promyelocytic leukemia (APL). Preclinical studies suggest that As(2)O(3) induces apoptosis and possibly differentiation in APL cells. Like APL cells, neuroblastoma (NB) cells are thought to be arrested at an early stage of differentiation, and cells of highly malignant tumors fail to undergo spontaneous maturation. Both APL and NB cells can respond with differentiation to retinoic acid (RA) treatment in vitro and probably also in vivo. For that reason we investigated the effect of As(2)O(3) alone and in combination with RA on NB cell lines. In vitro, the number of viable NB cells was reduced at As(2)O(3) concentrations around 1 microM after 72 h exposure. The IC50 in six different cell lines treated for 3 days was in the 1.5 to 5 microM concentration interval, the most sensitive being SK-N-BE(2) cells derived from a chemotherapy resistant tumor. The combined treatment with RA (1 and 3 microM) showed no consistent additional effect with regard to induced cell death. The effect of As(2)O(3) on NB cell number involved As(2)O(3)-induced apoptotic pathways (decreased expression of Bcl-2 and stimulation of caspase-3 activity) with no clear evidence of induced differentiation. The in vivo effect of As(2)O(3) on NB growth was also investigated in nude mice bearing tumors of xenografted NB cells. Although tumor growth was reduced by As(2)O(3) treatment, complete remission was not achieved at the concentrations tested. We suggest that As(2)O(3), in combination with existing treatment modalities, might be a treatment approach for high risk NB patients." @default.
• W2009604927 created "2016-06-24" @default.
• W2009604927 creator A5005521223 @default.
• W2009604927 creator A5006236423 @default.
• W2009604927 creator A5011903871 @default.
• W2009604927 creator A5039501726 @default.
• W2009604927 creator A5051135936 @default.
• W2009604927 creator A5054216397 @default.
• W2009604927 creator A5056325791 @default.
• W2009604927 date "2000-10-01" @default.
• W2009604927 modified "2023-10-09" @default.
• W2009604927 title "Arsenic Trioxide Inhibits Neuroblastoma Growth in Vivo and Promotes Apoptotic Cell Death in Vitro" @default.
• W2009604927 cites W1554600230 @default.
• W2009604927 cites W1877527541 @default.
• W2009604927 cites W1966176123 @default.
• W2009604927 cites W1975706542 @default.
• W2009604927 cites W1988993069 @default.
• W2009604927 cites W1989867979 @default.
• W2009604927 cites W2000646975 @default.
• W2009604927 cites W2000836105 @default.
• W2009604927 cites W2006918675 @default.
• W2009604927 cites W2016446826 @default.
• W2009604927 cites W2022212916 @default.
• W2009604927 cites W2047235581 @default.
• W2009604927 cites W2101617519 @default.
• W2009604927 cites W2104102972 @default.
• W2009604927 cites W2108362314 @default.
• W2009604927 cites W2120469846 @default.
• W2009604927 cites W2133935930 @default.
• W2009604927 cites W2142423276 @default.
• W2009604927 cites W2184391500 @default.
• W2009604927 cites W2242790540 @default.
• W2009604927 cites W2314037093 @default.
• W2009604927 cites W2322738006 @default.
• W2009604927 cites W2327522594 @default.
• W2009604927 cites W2334426218 @default.
• W2009604927 cites W2342635774 @default.
• W2009604927 cites W643483198 @default.
• W2009604927 doi "https://doi.org/10.1006/bbrc.2000.3651" @default.
• W2009604927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11027660" @default.
• W2009604927 hasPublicationYear "2000" @default.
• W2009604927 type Work @default.
• W2009604927 sameAs 2009604927 @default.
• W2009604927 citedByCount "57" @default.
• W2009604927 countsByYear W20096049272012 @default.
• W2009604927 countsByYear W20096049272013 @default.
• W2009604927 countsByYear W20096049272014 @default.
• W2009604927 countsByYear W20096049272015 @default.
• W2009604927 countsByYear W20096049272017 @default.
• W2009604927 countsByYear W20096049272018 @default.
• W2009604927 countsByYear W20096049272019 @default.
• W2009604927 countsByYear W20096049272021 @default.
• W2009604927 crossrefType "journal-article" @default.
• W2009604927 hasAuthorship W2009604927A5005521223 @default.
• W2009604927 hasAuthorship W2009604927A5006236423 @default.
• W2009604927 hasAuthorship W2009604927A5011903871 @default.
• W2009604927 hasAuthorship W2009604927A5039501726 @default.
• W2009604927 hasAuthorship W2009604927A5051135936 @default.
• W2009604927 hasAuthorship W2009604927A5054216397 @default.
• W2009604927 hasAuthorship W2009604927A5056325791 @default.
• W2009604927 hasConcept C104317684 @default.
• W2009604927 hasConcept C148738053 @default.
• W2009604927 hasConcept C150903083 @default.
• W2009604927 hasConcept C185592680 @default.
• W2009604927 hasConcept C190283241 @default.
• W2009604927 hasConcept C202751555 @default.
• W2009604927 hasConcept C203014093 @default.
• W2009604927 hasConcept C207001950 @default.
• W2009604927 hasConcept C2776601000 @default.
• W2009604927 hasConcept C2776715637 @default.
• W2009604927 hasConcept C2778461978 @default.
• W2009604927 hasConcept C2779963572 @default.
• W2009604927 hasConcept C2780386689 @default.
• W2009604927 hasConcept C2781121885 @default.
• W2009604927 hasConcept C31573885 @default.
• W2009604927 hasConcept C502942594 @default.
• W2009604927 hasConcept C54355233 @default.
• W2009604927 hasConcept C55493867 @default.
• W2009604927 hasConcept C62112901 @default.
• W2009604927 hasConcept C81885089 @default.
• W2009604927 hasConcept C86803240 @default.
• W2009604927 hasConceptScore W2009604927C104317684 @default.
• W2009604927 hasConceptScore W2009604927C148738053 @default.
• W2009604927 hasConceptScore W2009604927C150903083 @default.
• W2009604927 hasConceptScore W2009604927C185592680 @default.
• W2009604927 hasConceptScore W2009604927C190283241 @default.
• W2009604927 hasConceptScore W2009604927C202751555 @default.
• W2009604927 hasConceptScore W2009604927C203014093 @default.
• W2009604927 hasConceptScore W2009604927C207001950 @default.
• W2009604927 hasConceptScore W2009604927C2776601000 @default.
• W2009604927 hasConceptScore W2009604927C2776715637 @default.
• W2009604927 hasConceptScore W2009604927C2778461978 @default.
• W2009604927 hasConceptScore W2009604927C2779963572 @default.
• W2009604927 hasConceptScore W2009604927C2780386689 @default.
• W2009604927 hasConceptScore W2009604927C2781121885 @default.
• W2009604927 hasConceptScore W2009604927C31573885 @default.
• W2009604927 hasConceptScore W2009604927C502942594 @default.
• W2009604927 hasConceptScore W2009604927C54355233 @default.

• next